"The voice for cancer physicians and their patients in Massachusetts."

The Centers for Medicare and Medicaid Services (CMS) has issued a J-code for crizanlizumab-tmca (Adakveo)

29 Jun 2020 7:15 AM | Nathan Strunk (Administrator)

For dates of service on or after July 1, 2020, the Centers for Medicare and Medicaid Services (CMS) has issued a product-specific J-code: J0791 for injection, crizanlizumab-tmca (Adakveo), 5 mg. The updated billing unit is 5 mg.

Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451

Waltham, MA. 02451

P.O. Box 549154, Waltham, MA, 02451
t: 781.434.7329 | f: 781.464.4896 |email: nstrunk@mms.org
Powered by Wild Apricot Membership Software